|
1 |
14 05 2026 |
Indian regulators tighten drug quality oversight as substandard and spurious medicine cases rise in five years |
Pharmabiz |
India |
|
2 |
14 05 2026 |
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion |
Silicon India |
India |
|
3 |
14 05 2026 |
Indian pharma firms flood west Africa with powerful opioids despite crackdown: AFP investigation |
Economic Times |
India |
|
4 |
14 05 2026 |
Weight-loss drug semaglutide set to get cheaper as generic wave builds in India |
Health world (Economic Times) |
India |
|
5 |
14 05 2026 |
Zydus Life acquires US-based Assertio for $166 million cash |
Health world (Economic Times) |
India |
|
6 |
14 05 2026 |
Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push |
Indian Pharma Post |
India |
|
7 |
14 05 2026 |
CDSCO cancels registration of 'Elementre-MD Peel -Tri AHA' over safety misleading claim concerns |
Medical Dialogues |
India |
|
8 |
14 05 2026 |
Panel recommends CDSCO to develop uniform mechanism to handle misleading ads of Ayush products |
Pharmabiz |
India |
|
9 |
14 05 2026 |
OneSource Specialty Pharma Board Decides Against Pursuing Composite Merger Scheme in Current Form |
Scan x Trade |
India |
|
10 |
14 05 2026 |
USFDA chief Marty Makary resigns amid Trump clash over flavoured Vape drug decisions |
Medical Dialogues |
USA |
|
11 |
13 05 2026 |
Generic entry triggers explosive growth in India’s GLP-1 agonist market during April 2026 |
Pharmabiz |
India |
|
12 |
13 05 2026 |
Indian pharma sees Maersk cold-chain rail service as game-changer for medicine exporters |
Pharmabiz |
India |
|
13 |
13 05 2026 |
Imports of bulk drugs decline 3.31 per cent in FY26 |
Pharmabiz |
India |
|
14 |
13 05 2026 |
KPRDO seeks robust implementation of circular on unauthorized online medicine sales |
Pharmabiz |
India |
|
15 |
13 05 2026 |
Sildenafil , Tadalafil under scanner as DCGI launches crackdown on illegal sexual enhancement drug sale |
Medical Dialogues |
India |
|
16 |
13 05 2026 |
Drug Regulator To Meet Pharma Industry To Review High-Risk Solvents In Cough Syrups |
News 18 |
India |
|
17 |
13 05 2026 |
Dr Reddy’s set to scale up Semaglutide generic franchise, trims oncology pipeline |
Health world (Economic Times) |
India |
|
18 |
13 05 2026 |
Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy |
Health world (Economic Times) |
India |
|
19 |
13 05 2026 |
Indian pharmaceutical market crosses Rs 21,745 crore with 10.3 per cent growth in April 2026 |
Biospectrum |
India |
|
20 |
12 05 2026 |
DCGI to inaugurate 11th Pharmac South 2026 on June 4 in Chennai |
Pharmabiz |
India |
